Medical and Pharmaceutical Owlstone Medical gets up to US$49.1M to develop multi-cancer breath tests Urine samples will also be examined to detect various solid tumours Rowan DunneOctober 7, 2025
AI and Autonomy Hong Kong researchers deploy AI to revolutionize lung cancer diagnosis Caretia’s platform can serve as an initial reader of CT scans, flagging nodules with diameters of at least 5 millimeters. Joseph MortonOctober 6, 2025
Medical and Pharmaceutical Ohio university awarded almost half a million for lung cancer studies University of Dayton researchers will be focusing on the world's most prevalent type of the disease Rowan DunneOctober 6, 2025
Medical and Pharmaceutical Guardant Health backs lung cancer screening advocacy campaign The aim is to enhance public understanding about proper screening and biomarker testing diligence Rowan DunneSeptember 30, 2025
Medical and Pharmaceutical bioAffinity Technologies shines After CyPath Lung Clinical case studies CyPath Lung showed remarkable accuracy in identifying lung cancer at its earliest stage Joseph MortonSeptember 29, 2025
Medical and Pharmaceutical Dogs detect lung cancer in breath samples with 78% accuracy, study finds They helped to diagnose dozens of people with the respiratory disease Rowan DunneSeptember 26, 2025
Medical and Pharmaceutical Breath Diagnostics leaders promote their mission at Miami investment conference The National Investment Banking Association's event unites micro and small cap companies with potential investors Rowan DunneSeptember 21, 2025
Medical and Pharmaceutical Lung cancer detection dominates as breath biopsy gains clinical traction Clinicians, researchers, and healthcare systems increasingly rely on breath biopsy to detect chronic diseases early Joseph MortonSeptember 12, 2025
Medical and Pharmaceutical Breath Diagnostics adopts state-of-the-art mass spectrometer device for lung screening The Xevo TQ Absolute XR is one of the most sensitive and compact tandem quadrupole mass spectrometers available Rowan DunneSeptember 8, 2025
Medical and Pharmaceutical Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug The approval marked a pivotal milestone for the company, transitioning it from a clinical-stage entity to a commercial-stage player Joseph MortonSeptember 5, 2025